首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
【24h】

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

机译:类风湿关节炎患者对既往的单个TNF抑制剂无反应的利妥昔单抗与另一种TNF抑制剂的比较:SWITCH-RA,一项全球性,观察性,比较有效性研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis (RA) with an inadequate response to one previous TNFi.
机译:目的比较利妥昔单抗与替代性肿瘤坏死因子(TNFi)抑制剂(TNFi)在类风湿性关节炎(RA)患者中对先前一种TNFi应答不足的患者的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号